Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 23
84
Views
4
CrossRef citations to date
0
Altmetric
Research Articles

Anti-inflammatory and ulcerogenic activity of newer phytoisolates of Swertia alata C.B. Clarke

, , , &
Pages 5055-5065 | Received 16 Jan 2020, Accepted 17 May 2020, Published online: 05 Jun 2020

References

  • Alatab S, Sepanlou SG, Ikuta K, Vahedi H, Bisignano C, Safiri S, Sadeghi A, Nixon MR, Abdoli A, Abolhassani H, et al. 2020. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol. 5(1):17–30.
  • Bajaj S, Wakode S. 2017. Pharmacognostical evaluation and anthelmentic activity of Swertia alata. Int J Pharm. 8(8):3315–3324.
  • Bajpai MB, Asthana RK, Sharma NK, Chatterjee SK, Mukherjee SK. 1991. Hypoglycemic effect of swerchirin from the hexane fraction of Swertia chirayita. Planta Med. 57(2):102–104.
  • Blobaum AL, Lawrence JM. 2007. Structural and functional basis of cyclooxygenase inhibition. J Med Chem. 50(7):1425–1441.
  • Boyle EA, Freeman PC, Mangan FR, Thomson MJ. 1982. Nabumetone (BRL 14777, 4-[6-methoxy-2-naphthyl]-butan-2-one): a new anti-inflammatory agent. J Pharm Pharmacol. 34(9):562–569.
  • Brahmachari G, Mondal S, Gangopadhyay A, Gorai D, Mukhopadhyay B, Saha S, Brahmachari AK. 2004. Swertia (Gentianaceae): chemical and pharmacological aspects. Chem Biodivers. 1(11):1627–1651.
  • Brattsand R, Thalen A, Roempke K, Kallstrom L, Gruvstad E. 1982. Influence of 16 alpha, 17 alpha-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of glucocorticoids. J Steroid Biochem. 16(6):779–786.
  • Brooks P, Emery P, Evans JF, Fenner H, Hawkey CJ, Patrono C, Smolen J, Breedveld F, Day R, Dougados M, et al. 1999. Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford). 38(8):779–788.
  • Chhabria MT, Doda JM. 2005. Synthesis and anti-inflammatory activity of some novel 2-phenyl-3-methylthio-3-(substituted) arylamino acrylamide. Indian Drugs. 42(9):604–608.
  • Cioli V, Putzolu S, Rossi V, Scorza Barcellona P, Corradino C. 1979. The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. Toxicol Appl Pharm. 50(2):283–289.
  • Craig C, Graham DJ, Campen D, Hui R, Spence M, Levy G, Shoor S. 2008. Myocardial infarction and its association with the use of nonselective NSAIDs: a nested case–control and time-to-event analysis. Perm J. 12(1):16–22.
  • Crunkhorn P, Meacock SC. 1971. Mediators of the inflammation induced in the rat paw by carrageenin. Br J Pharmacol. 42(3):392–402.
  • Dutt R, Kumar S, Dhar V. 2007. Evaluation of analgesic activity of Solanum platanifolium. Sims Fruits Indian Drugs. 44(5):405–407.
  • Gabor M. 1986. Anti-inflammatory and anti-allergic properties of flavonoids. Prog Clin Biol Res. 213:471–480.
  • Guo Y-C, Chang C-M, Hsu W-L, Chiu S-J, Tsai Y-T, Chou Y-H, Hou M-F, Wang J-Y, Lee M-H, Tsai K-L, et al. 2013. Indomethacin inhibits cancer cell migration via attenuation of cellular calcium mobilization. Molecules. 18(6):6584–6596.
  • Herrera-Salgado Y, Garduno-Ramirez ML, Vazquez L, Rios MY, Alvarez L. 2005. Myo-inositol-derived glycolipids with anti-inflammatory activity from Solanum lanceolatum. J Nat Prod. 68(7):1031–1036.
  • Hippisley-Cox J, Coupland C. 2005. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case–control analysis. BMJ. 330(7504):1366.
  • Jiang W, Dong-Lai Z, Ming-Feng W, Qing-Song Y, Ma-Yi Z, Liang Z, Gan-Peng L. 2016. Xanthones from the herb of Swertia alata and their anti-TMV activity. Nat Prod Res. 30(16):1810–1815.
  • Karan M, Bhatnagar S, Wangtak P, Vasisht K. 2005. Phytochemical and antimalarial studies on Swertia alata Royle. Acta Hortic. 675:139–145.
  • Khetwal S, Pande S, Tiwari U. 1997. Xanthones from Swertia alata. Indian J Pharm Sci. 7: 190–191.
  • Kumar SGV, Mishra DN. 2006. Analgesic, anti-inflammatory and ulcerogenic studies of meloxicam solid dispersion in rodents. Iran J Pharm Res. 5(1):77–79.
  • Laavola M, Haavikko R, Hamalainen M, Leppanen T, Nieminen R, Alakurtti S, Moreira VM, Yli-Kauhaluoma J, Moilanen E. 2016. Betulin derivatives effectively suppress inflammation in vitro and in vivo. J Nat Prod. 79(2):274–280.
  • Lanas A, Perez-Aisa MA, Feu F, Ponce J, Saperas E, Santolaria S, Rodrigo L, Balanzo J, Bajador E, Almela P, et al.; Investigators of the Asociación Española de Gastroenterología (AEG). 2005. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol. 100(8):1685–1693.
  • MacNee W, Rabinovich RA, Choudhury G. 2014. Ageing and the border between health and disease. Eur Respir J. 44(5):1332–1352.
  • Mason JC, Libby P. 2015. Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. Eur Heart J. 36(8):482–489.
  • Mehta A, Raina R, Rana RC. 2017. Comparative morpho-histological studies of some Swertia species. J Pharmacogn Phytochem. 6(1):482–487.
  • Natrajan PN, Prasad S. 1972. Pharmacognostical Studies on Swertia alata. Proc Indian Acad Sci. 76 (4):171–180.
  • Negi JS, Singh P, Rawat B. 2011. Chemical constituents and biological importance of Swertia: a review. Curr Res Chem. 3(1):1–15.
  • Ogirala RG, Aldrich TK, Prezant DJ, Sinnett MJ, Enden JB, Williams MH. 1991. High-dose intramuscular triamcinolone in severe, chronic, life-threatening asthma. N Engl J Med. 324(9):585–589.
  • Pant N, Jain DC, Bhakuni RS. 2000. Phytochemicals from genus Swertia and their biological activities. Indian J Chem B. 39(8):565–586.
  • Patro BS, Chintalwar GJ, Chattopadhyay S. 2005. Antioxidant activities of Swertia decussata xanthones. Nat Prod Res. 19(4):347–354.
  • Sedgwick AD, Willoughby DA. 1989. Animal models for testing drugs on inflammatory and hypersensitivity reaction. In Foreman JC, Dale MM, editors. Textbook of immunology. 2nd ed. Oxford: Blackwell Scientific; p. 253–261.
  • Singh GB, Singh S, Bani S, Gupta BD, Banerjee SK. 1992. Anti-inflammatory activity of oleanolic acid in rats and mice. J Pharm Pharmacol. 44(5):456–458.
  • Taketo MM. 1998. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst. 90(20):1529–1536.
  • Takeuchi K, Akiko T, Shinichi K, Kikuko A, Hiroshi S. 2010. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta. 411(7–8):459–466.
  • Tapondjou LA, Lontsi D, Sondengam BL, Shaheen F, Choudhary MI, Rahman AU, Heerden FRV, Park HJ, Lee KT. 2003. Saponins from Cussonia bancoensis and their inhibitory effects on nitric oxide production. J Nat Prod. 66(9):1266–1269.
  • Turner RA, Hebborn P. 1971. Screening methods in pharmacology. New York: Academic Press.
  • Wallace JM. 2002. Nutritional and botanical modulation of the inflammatory cascade-eicosanoids, cyclooxygenases, and lipoxygenases-as an adjunct in cancer therapy. Integr Cancer Ther. 1(1):7–37.
  • Winter CA, Risley EA, Nuss GW. 1962. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 111(12):544–547.
  • Yang L, Jiang ST, Zhou QG, Zhong GY, He JW. 2017. Chemical constituents from the flower of Hosta plantaginea with cyclooxygenases inhibition and antioxidant activities and their chemotaxonomic significance. Molecules. 22(11):1825.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.